Treatment of stingray injury with topical becaplermin gel.
Stingray injuries are most commonly characterized by localized pain, ulceration, and edema; however, potentially serious sequelae may result, including tissue necrosis and life-threatening infection. This case report describes a stingray injury that had progressed to ulceration and was treated with topical application of recombinant human platelet-derived growth factor-BB (becaplermin gel 0.01%) and a standardized regimen of wound care.
Baldinger
P J
PJ
Cortez Podiatry Associates, Bradenton, FL 34207, USA.
D000818:Animals; D000077214:Becaplermin; D005399:Fishes; D018409:Foot Injuries / Q000188:drug therapy* / Q000209:etiology; D016523:Foot Ulcer / Q000209:etiology; D005547:Foreign Bodies; D005782:Gels; D006801:Humans; D008297:Male; D008875:Middle Aged; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*
D005782:Gels; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin